The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Mar. 14, 2013
Applicant:

Oncomed Pharmaceuticals, Inc., Redwood City, CA (US);

Inventors:

Austin L. Gurney, San Francisco, CA (US);

Timothy Charles Hoey, Hillsborough, CA (US);

Edward Thein Htun van der Horst, Palo Alto, CA (US);

Aaron Ken Sato, Burlingame, CA (US);

Yuan Ching Liu, Fremont, CA (US);

Maureen Fitch Bruhns, San Mateo, CA (US);

John A. Lewicki, Los Gatos, CA (US);

Assignee:

OncoMed Pharmaceuticals, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/46 (2006.01); C07K 16/22 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 14/435 (2006.01); C12N 15/63 (2006.01); C12N 15/79 (2006.01); C07H 21/04 (2006.01); C12N 5/12 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); C07K 16/28 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/462 (2013.01); C07K 16/464 (2013.01); C07K 16/22 (2013.01); C07K 14/435 (2013.01); C12N 15/63 (2013.01); C12N 15/79 (2013.01); C07H 21/04 (2013.01); C12N 5/12 (2013.01); A61K 39/3955 (2013.01); C07K 14/71 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2317/56 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01);
Abstract

The present invention relates to Notch-binding agents and Notch antagonists and methods of using the agents and/or antagonists for treating diseases such as cancer. The present invention provides antibodies that specifically bind to a non-ligand binding region of the extracellular domain of one or more human Notch receptor, such as Notch2 and/or Notch3, and inhibit tumor growth. The present invention further provides methods of treating cancer, the methods comprising administering a therapeutically effective amount of an antibody that specifically binds to a non-ligand binding region of the extracellular domain of a human Notch receptor protein and inhibits tumor growth.


Find Patent Forward Citations

Loading…